Tianjin Medical University General Hospital

This study tests a new treatment called 'Modified Zipper Therapy' for people with a rare autoimmune disease called NMOSD. The therapy combines standard treatments (steroids and plasma exchange) with a drug called eculizumab to block a part of the immune system. The goal is to see…

This study tests whether eculizumab can quickly reduce disability during acute attacks of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the brain and spinal cord. About 110 adults who test positive for the AQP4 antibody and are having an a…

This study is creating a large digital registry for people with monogenic diabetes (a rare form caused by a single gene). Researchers will use a mobile app and website to enroll up to 5,000 participants and perform genetic testing. The goal is to learn more about the genetic caus…